Dec 14 2009
ICON plc, (NASDAQ:ICLR), a global provider of outsourced
development services to the pharmaceutical, biotechnology and medical
device industries, today announced that it has expanded its European
Central Laboratory, located in South County Business Park, Dublin. The
newly-designed 41,000 sq ft (3,800m²) facility, which is three times the
size of the previous laboratory, provides centralised testing and site
support services to clinical investigators in over 70 countries
throughout Europe, Middle East and Africa.
The new laboratory incorporates enhanced automation which will enable
reductions in turn-around time for sample testing and reporting, and has
quadrupled the laboratory’s sample management and storage capacity. In
addition, the larger facility has enabled the introduction of new
platforms to enhance ICON’s test menu in specialised areas including
microbiology, molecular diagnostics, flow cytometry, endocrinology and
RIA. New dedicated laboratories have also been created to accommodate
more specialised testing services in the areas of anatomic pathology,
molecular diagnostics and multiplex assays, which will be operational in
early 2010.
“Efficient sample management and reporting, and providing an extensive
test menu are key fundamentals of any laboratory,” commented Peter Gray,
CEO at ICON plc. “The extra capacity in our Dublin laboratory enables
ICON to extend our capabilities to support clients’ demands for more
sophisticated testing. ICON Central Laboratories Dublin will continue to
act as an important central hub for global trials and we look forward to
delivering effective laboratory services to an even greater number of
sponsors and investigators around the world.”
http://www.iconplc.com/